Urol. praxi. 2019;20(1):40-41 | DOI: 10.36290/uro.2019.045

Inflammatory myofibroblastic tumor

MUDr. Veronika Marcináková, MUDr. Hana Dittrichová, MUDr. Karel Franěk, MUDr. Pavel Hanek
Urologické oddělení Oblastní nemocnice Příbram, a. s.

We report a case of an uncommon malignancy of the urinary bladder in a 42-year-old male, removed via transurethral resection.
Inflammatory myofibroblastic tumor, a neoplasm of uncertain malignant potential, is characterised by spindle myoepithelial cell
proliferation and rich lymphocytic infiltrate. Disease occurs in internal organs and soft tissues of any body location. Diagnostics
is based on histologic examination, immunostaing and genetic mapping, which can help to identify typical genetic aberrations.
The treatment of choice is complete surgical resection. The overall prognosis is good.

Keywords: inflammatory myofibroblastic tumor, rare type of bladder cancer, ALK gene

Published: March 18, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Marcináková V, Dittrichová H, Franěk K, Hanek P. Inflammatory myofibroblastic tumor. Urol. praxi. 2019;20(1):40-41. doi: 10.36290/uro.2019.045.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Arora K. Inflammatory myofibroblastic tumor of soft tissue. PathologyOutlines.com website. Dostupné z: http://www.pathologyoutlines.com/topic/softtissueinflammyofibro.html.
    2. Yagnik V, Chadha A, Chaudhari S, Patel K. Inflammatory myofibroblastic tumor of the urinary bladder. Urol Ann. 2010 May-Aug; 2(2): 78-79. Go to original source... Go to PubMed...
    3. Hammas N, Chbani L, Rami M, et al. A rare tumor of the lung: inflammatory myofibroblastic tumor. Diagn Pathol. 2012 Jul 17; 7: 83. Go to original source... Go to PubMed...
    4. Coffin CM, Hornick JL, Fletcher CDM. Inflammatory myofibroblastic tumour: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007; 31: 509-520. Go to original source... Go to PubMed...
    5. Telugu RB, Prabhu AJ, Kalappurayil NB, Mathai J, Gnanamuthu BR, Manipadam MT. Clinicopathological Study of 18 Cases of Inflammatory Myofibroblastic Tumors with Reference to ALK-1 Expression: 5-Year Experience in a Tertiary Care Center. J Pathol Transl Med. 2017 May; 51(3): 255-263. Go to original source... Go to PubMed...
    6. Patnana M, Sevrukov AB, Elsayes KM, Viswanathan C, Lubner M, Menias CO. Inflammatory pseudotumour: the great mimicker. AJR Am J Roentgenol. 2012; 198: 217-227. Go to original source... Go to PubMed...
    7. Adamkov J, Kasparova P, Cesak T. Inflammatory Pseudotumor Imitating Intracranial Meningioma - a Case Report. Cesk Slov Neurol N 2015; 78/111(2): 233-236.
    8. Gleason BC, Hornick JL, Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol. 2008 Apr; 61(4): 428-437. Go to original source... Go to PubMed...
    9. Kim SH, Cho JY, Kim SH. Inflammatory myofibroblastic pseudotumor of the urinary bladder in a patient with bilateral renal cell carcinoma. J Ultrasound Med. 2008 Mar; 27(3): 483-486. Go to original source... Go to PubMed...
    10. Podhorec J, Tomášek J, Kiss I, a kol. Regrese metastatického inflamatorního myofibroblastického tumoru pankreatu po chemoterapii - kazuistika. 2014; XX/299: 103.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.